Conserved, high-activity, red blood cell binding malaria peptide 6786, from the HRP-I protein, having a random 3D structure as determined by 1H-NMR, was non-immunogenic and non-protection inducing when used as an immunogen in Aotus monkeys. Modifications made in its amino acid sequence were thus performed to render it immunogenic and protection inducing. Non-immunogenic, non-protection inducing modified peptide 13852 presented A2-H8 and K14-L18 helix fragments. Immunogenic, non-protection inducing modified peptide 23428 presented a short, displaced helix in a different region, whilst immunogenic, protection inducing peptide 24224 had 2 displaced helical regions towards the central region giving more flexibility to its N- and C-terminals. Im...
The Plasmodium falciparum circumsporozoite protein is considered a major antimalarial-vaccine target...
The serine repeat antigen (SERA) protein is a leading candidate molecule for inclusion as a componen...
As microbes use many mechanisms for avoiding immunological pressure, new strategies must be develope...
An effective malarial vaccine must contain multiple immunogenic, protection-inducing epitopes able t...
An anti-malarial vaccine is urgently needed, especially against P. falciparum which causes 2 to 3 mi...
Immunogenic and protective peptide sequences are of prime importance in the search for an anti-malar...
The Plasmodium falciparum acidic–basic repeat antigen represents a potential malarial vaccine candid...
SERA protein is a leading candidate molecule to be included in an antimalarial vaccine. Conserved hi...
The protein called serine repeat antigen (SERA) is a Plasmodium falciparum malaria antigen; high act...
Plasmodium falciparum malaria protein peptides were synthesised in the search for more effective rou...
The Plasmodium falciparum malaria parasite produces several proteins characterised by an unusually h...
The erythrocyte binding antigen EBA-175 is a 175-kDa Plasmodium falciparum protein, which has been s...
Obtaining a highly effective malaria vaccine is a worldwide priority. The first approach aimed at ob...
Introduction•P. falciparum invasion of RBCs•Merozoite proteins involved in invading erythrocytes•Ery...
EBA-175 protein is used as a ligand in the binding of P. falciparum to red blood cells (RBCs). Evide...
The Plasmodium falciparum circumsporozoite protein is considered a major antimalarial-vaccine target...
The serine repeat antigen (SERA) protein is a leading candidate molecule for inclusion as a componen...
As microbes use many mechanisms for avoiding immunological pressure, new strategies must be develope...
An effective malarial vaccine must contain multiple immunogenic, protection-inducing epitopes able t...
An anti-malarial vaccine is urgently needed, especially against P. falciparum which causes 2 to 3 mi...
Immunogenic and protective peptide sequences are of prime importance in the search for an anti-malar...
The Plasmodium falciparum acidic–basic repeat antigen represents a potential malarial vaccine candid...
SERA protein is a leading candidate molecule to be included in an antimalarial vaccine. Conserved hi...
The protein called serine repeat antigen (SERA) is a Plasmodium falciparum malaria antigen; high act...
Plasmodium falciparum malaria protein peptides were synthesised in the search for more effective rou...
The Plasmodium falciparum malaria parasite produces several proteins characterised by an unusually h...
The erythrocyte binding antigen EBA-175 is a 175-kDa Plasmodium falciparum protein, which has been s...
Obtaining a highly effective malaria vaccine is a worldwide priority. The first approach aimed at ob...
Introduction•P. falciparum invasion of RBCs•Merozoite proteins involved in invading erythrocytes•Ery...
EBA-175 protein is used as a ligand in the binding of P. falciparum to red blood cells (RBCs). Evide...
The Plasmodium falciparum circumsporozoite protein is considered a major antimalarial-vaccine target...
The serine repeat antigen (SERA) protein is a leading candidate molecule for inclusion as a componen...
As microbes use many mechanisms for avoiding immunological pressure, new strategies must be develope...